{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T05:14:56Z","timestamp":1778822096554,"version":"3.51.4"},"reference-count":46,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,10,1]],"date-time":"2017-10-01T00:00:00Z","timestamp":1506816000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100006055","name":"CSN","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100006055","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["physicamedica.com","clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Physica Medica"],"published-print":{"date-parts":[[2017,10]]},"DOI":"10.1016\/j.ejmp.2017.03.025","type":"journal-article","created":{"date-parts":[[2017,4,7]],"date-time":"2017-04-07T02:46:59Z","timestamp":1491533219000},"page":"277-284","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":12,"special_numbering":"C","title":["Uncomplicated and Cancer-Free Control Probability (UCFCP): A new integral approach to treatment plan optimization in photon radiation therapy"],"prefix":"10.1016","volume":"42","author":[{"given":"Beatriz","family":"S\u00e1nchez-Nieto","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maite","family":"Romero-Exp\u00f3sito","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jos\u00e9 A.","family":"Terr\u00f3n","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Francisco","family":"S\u00e1nchez-Doblado","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejmp.2017.03.025_b0005","doi-asserted-by":"crossref","first-page":"1386","DOI":"10.1118\/1.3685447","article-title":"The use and QA of biologically related models for treatment planning: Short report of the TG-166 of the therapy physics committee of the AAPM","volume":"39","author":"Li","year":"2012","journal-title":"Med Phys"},{"key":"10.1016\/j.ejmp.2017.03.025_b0010","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1016\/S0360-3016(99)00029-2","article-title":"The \u0394TCP concept: a clinically useful measure of Tumour Control Probability","volume":"44","author":"S\u00e1nchez-Nieto","year":"1999","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ejmp.2017.03.025_b0015","first-page":"86","article-title":"Application of biological models: a) IMRT for pelvic tumours and oesophageal cancer, b) prescription dose individualisation","volume":"17","author":"S\u00e1nchez-Nieto","year":"2001","journal-title":"Phys Medica"},{"key":"10.1016\/j.ejmp.2017.03.025_b0020","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1259\/bjr.75.890.750151","article-title":"Potential improvements in the therapeutic ratio of prostate cancer irradiation: dose escalation of pathologically identified tumour nodules using IMRT","volume":"75","author":"Nutting","year":"2002","journal-title":"Br J Radiol"},{"key":"10.1016\/j.ejmp.2017.03.025_b0025","doi-asserted-by":"crossref","first-page":"S10","DOI":"10.1016\/j.ijrobp.2009.07.1754","article-title":"Use of normal tissue complication probability models in the clinic","volume":"76","author":"Marks","year":"2010","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ejmp.2017.03.025_b0030","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1259\/bjr.74.882.740529","article-title":"Radiation carcinogenesis modelling for risk of treatment related second tumours following radiotherapy","volume":"74","author":"Lindsay","year":"2001","journal-title":"Br J Radiol"},{"key":"10.1016\/j.ejmp.2017.03.025_b0035","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1080\/02841860510029833","article-title":"The use of risk estimation models for the induction of secondary cancers following radiotherapy","volume":"44","author":"Da\u015fu","year":"2005","journal-title":"Acta Oncol"},{"key":"10.1016\/j.ejmp.2017.03.025_b0040","first-page":"012049","article-title":"Integration of second cancer risk calculations in a radiotherapy treatment planning system","volume":"489","author":"Hartmann","year":"2014","journal-title":"J Phys: Conf Ser"},{"key":"10.1016\/j.ejmp.2017.03.025_b0045","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1016\/S1470-2045(11)70061-4","article-title":"Proportion of second cancers attributable to radiotherapy treatment in adults: a cohort study in the US SEER cancer registries","volume":"12","author":"Berrington de Gonzalez","year":"2011","journal-title":"Lancet Oncol"},{"issue":"1","key":"10.1016\/j.ejmp.2017.03.025_b0050","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/j.radonc.2011.09.013","article-title":"Second cancer after radiotherapy, 1981\u20132007","volume":"105","author":"Bartkowiak","year":"2012","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.ejmp.2017.03.025_b0055","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/S0360-3016(03)00073-7","article-title":"Radiation-induced second cancers: the impact of 3D-CRT and IMRT","volume":"56","author":"Hall","year":"2003","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ejmp.2017.03.025_b0060","series-title":"Neutron contamination from medical accelerators","author":"NCRP. National Council on Radiation Protection and Measurements","year":"1984"},{"key":"10.1016\/j.ejmp.2017.03.025_b0065","doi-asserted-by":"crossref","first-page":"3734","DOI":"10.1118\/1.2349699","article-title":"In vivo and phantom measurements of the secondary photon and neutron doses for prostate patients undergoing 18 MV IMRT","volume":"33","author":"Reft","year":"2006","journal-title":"Med Phys"},{"key":"10.1016\/j.ejmp.2017.03.025_b0070","doi-asserted-by":"crossref","first-page":"920","DOI":"10.1016\/j.ijrobp.2010.04.025","article-title":"Volumetric arc therapy and intensity-modulated radiotherapy for primary prostate radiotherapy with simultaneous integrated boost to intraprostatic lesion with 6 and 18 MV: A planning comparison study","volume":"7","author":"Ost","year":"2011","journal-title":"Int J Rad Oncol Biol Phys"},{"key":"10.1016\/j.ejmp.2017.03.025_b0075","series-title":"The physics of three-dimensional radiation therapy","first-page":"1","article-title":"Three dimensional radiation-therapy treatment planning","author":"Webb","year":"1993"},{"key":"10.1016\/j.ejmp.2017.03.025_b0080","series-title":"Radiation Effects and Tolerance, Normal Tissue","first-page":"512","article-title":"Discussion Radiotherapy and Tolerance1","volume":"6","author":"Mendelsohn","year":"1972"},{"key":"10.1016\/j.ejmp.2017.03.025_b0085","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1088\/0031-9155\/38\/6\/001","article-title":"A model for calculating tumour control probability in radiotherapy including the effects of inhomogeneous distributions of dose and clonogenic cell density","volume":"38","author":"Webb","year":"1993","journal-title":"Phys Med Biol"},{"key":"10.1016\/j.ejmp.2017.03.025_b0090","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1016\/S0360-3016(03)00534-0","article-title":"Incorporating clinical measurements of hypoxia into tumor local control modelling of prostate cancer: Implications for the \u03b1\/\u03b2 ratio","volume":"57","author":"Nahum","year":"2003","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ejmp.2017.03.025_b0095","doi-asserted-by":"crossref","first-page":"S13","DOI":"10.2307\/3576626","article-title":"Complication probabilities as assessed from dose-volume histograms","volume":"104","author":"Lyman","year":"1985","journal-title":"Radiat Res"},{"key":"10.1016\/j.ejmp.2017.03.025_b0100","doi-asserted-by":"crossref","first-page":"1623","DOI":"10.1016\/0360-3016(89)90972-3","article-title":"Calculation of complication probabilityfactors for non uniform normal tissue irradiation: the effective volume method","volume":"16","author":"Kutcher","year":"1989","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ejmp.2017.03.025_b0105","first-page":"S123","article-title":"Radiation dose-volume effects in radiation-induced rectal injury","volume":"76","author":"Michalski","year":"2010","journal-title":"Int J RadiatOncolBiol Phys"},{"key":"10.1016\/j.ejmp.2017.03.025_b0110","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/S0958-3947(00)00031-5","article-title":"Bioplan: a software for the biological evaluation of treatment plans","volume":"25","author":"S\u00e1nchez-Nieto","year":"2000","journal-title":"Med Dosim"},{"issue":"23","key":"10.1016\/j.ejmp.2017.03.025_b0115","doi-asserted-by":"crossref","first-page":"7009","DOI":"10.1088\/0031-9155\/55\/23\/S04","article-title":"Methodology for determining doses to in-field, out-of-field and partially in-field organs for late effects studies in photon radiotherapy","volume":"55","author":"Howell","year":"2010","journal-title":"Phys Med Biol"},{"key":"10.1016\/j.ejmp.2017.03.025_b0120","doi-asserted-by":"crossref","first-page":"045205","DOI":"10.1088\/2057-1976\/1\/4\/045205","article-title":"Analytical model for photon peripheral dose estimation in radiotherapy treatments","volume":"1","author":"S\u00e1nchez-Nieto","year":"2015","journal-title":"Biomed Phys Eng Express"},{"key":"10.1016\/j.ejmp.2017.03.025_b0125","doi-asserted-by":"crossref","first-page":"6167","DOI":"10.1088\/0031-9155\/57\/19\/6167","article-title":"Estimation of neutron-equivalent dose in organs of patients undergoing radiotherapy by the use of a novel online digital detector","volume":"57","author":"S\u00e1nchez-Doblado","year":"2012","journal-title":"Phys Med Biol"},{"key":"10.1016\/j.ejmp.2017.03.025_b0130","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1088\/0031-9155\/55\/4\/008","article-title":"A new active method for the measurement of slow-neutron fluence in modern radiotherapy treatment rooms","volume":"55","author":"G\u00f3mez","year":"2010","journal-title":"Phys Med Biol"},{"key":"10.1016\/j.ejmp.2017.03.025_b0135","doi-asserted-by":"crossref","first-page":"112105","DOI":"10.1118\/1.4898591","article-title":"A new online detector for estimation of peripheral neutron equivalent dose in organ","volume":"41","author":"Irazola","year":"2014","journal-title":"Med Phys"},{"key":"10.1016\/j.ejmp.2017.03.025_b0140","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1016\/j.radonc.2013.03.011","article-title":"Neutron contamination in radiotherapy: Estimation of second cancers based on measurements in 1377 patients","volume":"107","author":"Exp\u00f3sito","year":"2013","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.ejmp.2017.03.025_b0145","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1118\/1.4903525","article-title":"Commissioning the neutron production of a linac: development of a simple tool for second cancer risk estimation","volume":"42","author":"Romero-Exp\u00f3sito","year":"2015","journal-title":"Med Phys"},{"key":"10.1016\/j.ejmp.2017.03.025_b0150","doi-asserted-by":"crossref","first-page":"13040","DOI":"10.1073\/pnas.0506648102","article-title":"Solid tumor risks after high doses of ionizing radiation","volume":"102","author":"Sachs","year":"2005","journal-title":"Proc Natl Acad Sci USA"},{"issue":"4","key":"10.1016\/j.ejmp.2017.03.025_b0155","doi-asserted-by":"crossref","first-page":"1138","DOI":"10.1118\/1.3089792","article-title":"Mechanistic model of radiation-induced cancer after fractionated radiotherapy using the linear-quadratic formula","volume":"36","author":"Schneider","year":"2009","journal-title":"Med Phys"},{"issue":"3","key":"10.1016\/j.ejmp.2017.03.025_b0160","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1007\/s00411-009-0230-3","article-title":"A new view of radiation-induced cancer: integrating short- and long-term processes, Part I: Approach","volume":"48","author":"Shuryak","year":"2009","journal-title":"Radiat Environ Biophys"},{"issue":"3","key":"10.1016\/j.ejmp.2017.03.025_b0165","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1007\/s00411-009-0231-2","article-title":"A new view of radiation-induced cancer: integrating short- and long-term processes, Part II: Second cancer risk estimation","volume":"48","author":"Shuryak","year":"2009","journal-title":"Radiat Environ Biophys"},{"issue":"7","key":"10.1016\/j.ejmp.2017.03.025_b0170","first-page":"2","article-title":"The 2007 Recommendations of the International Commission on Radiological Protection. ICRP Publication 103","volume":"3","author":"International Commission on Radiological Protection","year":"2007","journal-title":"Ann. ICRP"},{"key":"10.1016\/j.ejmp.2017.03.025_b0175","series-title":"Health Risks from Exposure to Low Levels of Ionizing Radiation: BEIR VII Phase 2","author":"National Research Council (NRC)","year":"2006"},{"issue":"5","key":"10.1016\/j.ejmp.2017.03.025_b0180","doi-asserted-by":"crossref","first-page":"1510","DOI":"10.1016\/j.ijrobp.2004.12.040","article-title":"Estimation of radiation-induced cancer from three-dimensional dose distributions: concept of organ equivalent dose","volume":"61","author":"Schneider","year":"2005","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ejmp.2017.03.025_b0185","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1186\/1742-4682-8-27","article-title":"Site-specific dose-response relationships for cancer induction from the combined Japanese A-bomb and Hodgkin cohorts for doses relevant to radiotherapy","volume":"8","author":"Schneider","year":"2011","journal-title":"Theor Biol Med Model"},{"key":"10.1016\/j.ejmp.2017.03.025_b0190","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1186\/1748-717X-8-255","article-title":"Assessment of organ dose reduction and secondary cancer risk associated with the use of proton beam therapy and intensity modulated radiation therapy in treatment of neuroblastomas","volume":"8","author":"Fuji","year":"2013","journal-title":"Radiat Oncol"},{"issue":"6","key":"10.1016\/j.ejmp.2017.03.025_b0195","first-page":"1","article-title":"United States life tables","volume":"50","author":"Anderson","year":"2002","journal-title":"Natl Vital Stat Rep"},{"key":"10.1016\/j.ejmp.2017.03.025_b0200","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/S0360-3016(00)01501-7","article-title":"Individualizing cancer treatment: biological optimization models in treatment planning and delivery","volume":"49","author":"Brahme","year":"2001","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"2","key":"10.1016\/j.ejmp.2017.03.025_b0205","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1016\/S0360-3016(00)01508-X","article-title":"Individualisation of dose prescription customisation based on normal-tissue dose-volume and radiosensitivity data","volume":"49","author":"S\u00e1nchez-Nieto","year":"2001","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"4","key":"10.1016\/j.ejmp.2017.03.025_b0210","first-page":"286","article-title":"Hypofractionated radiation therapy for prostate cancer: biologic and technical considerations","volume":"2","author":"Sanfilippo","year":"2014","journal-title":"Am J Clin Exp Urol"},{"key":"10.1016\/j.ejmp.2017.03.025_b0215","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1016\/j.ijrobp.2009.02.025","article-title":"Dose\u2013volume constraints to reduce rectal side effects from prostate radiotherapy: evidence from MRC RT01 trial ISRCTN 47772397","volume":"76","author":"Gulliford","year":"2010","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"2","key":"10.1016\/j.ejmp.2017.03.025_b0220","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1002\/(SICI)1097-0142(20000115)88:2<398::AID-CNCR22>3.0.CO;2-V","article-title":"Second malignancies in prostate carcinoma patients after radiotherapy compared with surgery","volume":"88","author":"Brenner","year":"2000","journal-title":"Cancer"},{"issue":"3","key":"10.1016\/j.ejmp.2017.03.025_b0225","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/S0167-8140(02)00307-9","article-title":"The risk of second malignancy in men with prostate cancer treated with or without radiation in British Columbia, 1984\u20132000","volume":"65","author":"Pickles","year":"2002","journal-title":"Radiother. Oncol."},{"key":"10.1016\/j.ejmp.2017.03.025_b0230","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.canep.2017.01.001","article-title":"Development of a model to predict the 10-year cumulative risk of second primary cancer among cancer survivors","volume":"47","author":"Moitry","year":"2017","journal-title":"Cancer Epidemiol."}],"container-title":["Physica Medica"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1120179717300844?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1120179717300844?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,2]],"date-time":"2018-09-02T22:52:45Z","timestamp":1535928765000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1120179717300844"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,10]]},"references-count":46,"alternative-id":["S1120179717300844"],"URL":"https:\/\/doi.org\/10.1016\/j.ejmp.2017.03.025","relation":{},"ISSN":["1120-1797"],"issn-type":[{"value":"1120-1797","type":"print"}],"subject":[],"published":{"date-parts":[[2017,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Uncomplicated and Cancer-Free Control Probability (UCFCP): A new integral approach to treatment plan optimization in photon radiation therapy","name":"articletitle","label":"Article Title"},{"value":"Physica Medica","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejmp.2017.03.025","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Associazione Italiana di Fisica Medica. Published by Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}